Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer's Paxlovid conducts head-to-head clinical research

  • Post date May 8, 2022 — 13:24 Post Lock Login to View

Key Data Concepts:   
? These are the company names, stock quotes, topics, and entities related to this data.

000925 002014 002486 300322 China Shipbuilding Industry Group Power Citic Securities Fujian Funeng Guotai Junan Securities Huangshan Novel Huizhou Speed Wireless Technology Jiangsu Hengrui Medicine Nanjing Pharmaceutical Shanghai Challenge Textile Company Limited Unittec Xiamen Amoytop Biotech Xinjiang Sayram Modern Agriculture Witness Accounting, Audit Layoffs, Downsizing Management Annual, Special Corporate Meeting Annual Report Research, Development Health, Beauty Product Pharmaceutical Gold, Precious Material Credit, Debt Market, Exchange Securities Stocks Cancer Epidemic Hospital Medicine Therapy Workplace Health, Safety Food, Drink Enthusiasm Small, Medium Enterprise Oncology Midsummer Health

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets


Join Now!

Need this critical market data?

Access thousands of market events, data points, and news articles!


Already have an account?
Login



Related Data